FATE THERAPEUTICS INC Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-13: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-13: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-13: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-13: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-13 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-13 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-13 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-13 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-05-13 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-13 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-13 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-13 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-24 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | Pay versus Performance Year Summary Compensation Table Total for PEO(1) ($) Compensation Actually Paid to PEO(2) ($) Summary Compensation Table Total for former PEO(1) ($) Compensation Actually Paid to former PEO(2) ($) Average Summary Compensation Table Total for Non-PEO Named Executive Officers(3)… | |
| 2026-04-24 DEF 14A | PEO Name | Individual: BahramValamehr | 2025-01-01..2025-12-31 | Bahram Valamehr |
| 2026-04-24 DEF 14A | PEO Name | Individual: JScottWolchko | 2024-01-01..2024-12-31 | J. Scott Wolchko |
| 2026-04-24 DEF 14A | PEO Name | Individual: JScottWolchko | 2023-01-01..2023-12-31 | J. Scott Wolchko |
| 2026-04-24 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | (2) The dollar amounts reported in column (c) represent the amount of “compensation actually paid” to Dr. Valamehr or Mr. Wolchko, as applicable, as computed in accordance with Item 402(v) of Regulation S-K during the applicable year. The dollar amounts do not reflect the actual amount of compensati… | |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | -$1.28M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | $681.68K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | $748.91K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | -$262.06K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | $361.34K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | -$166.53K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo; Individual: BahramValamehr | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | -$3.09M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | $510.12K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | -$2.60M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | -$1.28M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | $392.19K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | -$368.84K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | $450.54K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | $36.23K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | $1.05M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | -$1.80M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | $489.06K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | -$1.02M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: Peo; Individual: JScottWolchko | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (3) The dollar amounts reported in column (d) represent the average of the amounts reported for our company’s named executive officers as a group (excluding the applicable year’s PEO) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the named exec… | |
| 2026-04-24 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | (4) The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the named executive officers as a group (excluding the applicable year’s PEO), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual aver… | |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$475.40K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $136.49K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$2.84M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $605.23K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$2.26M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$5.39K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $305.90K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$128.31K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $38.04K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | -$79.14K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $687.46K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$498.98K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $394.23K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $22.52K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $908.68K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$1.04M |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $423.85K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$294.35K |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Adjustment To Compensation | AdjToComp: DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-24 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2025-01-01..2025-12-31 | Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Shareholder Return (“TSR”) The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Compa… | |
| 2026-04-24 DEF 14A | Compensation Actually Paid Vs Net Income | 2025-01-01..2025-12-31 | Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Net Income during the three most re… | |
| 2026-04-24 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-24 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Equity Grant Timing We have adopted an Amended and Restated Equity Award Grant Policy that sets forth the process and timing for us to follow when we grant equity awards for shares of our common stock to our employees, including our executive officers, or advisors or consultants to us or advisors or… | |
| 2026-04-24 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-24 DEF 14A | Award Timing Predetermined | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-24 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | Generally, equity awards are granted on the following regularly scheduled basis as set forth in the policy: • Equity awards granted by the Board of Directors, the Compensation Committee or its delegate(s) in connection with the hiring of a new employee or the promotion of an existing employee or the… | |
| 2026-02-26 10-K | Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-26 10-K | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-26 10-K | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-26 10-K | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-26 10-K | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |